Alivus Life Sciences (ALIVUS.BO) Earnings Analysis
Alivus Life Sciences (ALIVUS.BO) next reports earnings on 2026-07-31, consensus EPS 12.1 INR. Last quarter (2026-05-14) it beat with EPS 14.1 INR vs 11.7 INR est (+20.5%). It has beaten estimates in 3/5 recent quarters (60%). Trailing P/E 24.08.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ALIVUS.BO next report earnings?
| Next earnings date | 2026-07-31 |
|---|---|
| Consensus EPS estimate | 12.1 INR |
| Revenue estimate | 6.80B |
ALIVUS.BO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-14 | 14.1 INR | 11.7 INR | +20.5% | Beat |
| 2026-01-22 | 13.8 INR | 11.6 INR | +19% | Beat |
| 2025-08-01 | 9.08 INR | 9 INR | +0.9% | Beat |
| 2025-05-15 | 7.97 INR | 10.2 INR | -21.9% | Miss |
| 2024-10-24 | 7.75 INR | 10 INR | -22.5% | Miss |
Beat rate: 3/5 (60%) over reported quarters with consensus data.
ALIVUS.BO valuation and analyst view
| Trailing P/E | 24.08 |
|---|---|
| Trailing EPS | 45.912 INR |
| Price / book | 4.09 |
| Dividend yield | 0.45% |
| Market cap | 139.57B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Alivus Life Sciences (ALIVUS.BO)'s next earnings date?
Alivus Life Sciences is next scheduled to report on 2026-07-31, with a consensus EPS estimate of 12.1 INR and revenue estimate of 6.80B.
Did ALIVUS.BO beat earnings last quarter?
In its 2026-05-14 report, ALIVUS.BO posted EPS of 14.1 INR versus a 11.7 INR estimate — a beat of 20.5%.
What is ALIVUS.BO's earnings track record?
Over the last 5 reported quarters with consensus data, ALIVUS.BO beat estimates 3 times (60%).
What is ALIVUS.BO's current P/E ratio and EPS?
ALIVUS.BO trades at a trailing P/E of 24.08 on trailing EPS of 45.91196349705976 INR.
What do analysts rate ALIVUS.BO?
ALIVUS.BO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.